2021
Race, Income, and Survival in Stage III Colon Cancer: CALGB 89803 (Alliance)
Lee S, Zhang S, Ma C, Ou FS, Wolfe EG, Ogino S, Niedzwiecki D, Saltz LB, Mayer RJ, Mowat RB, Whittom R, Hantel A, Benson A, Atienza D, Messino M, Kindler H, Venook A, Gross CP, Irwin ML, Meyerhardt JA, Fuchs CS. Race, Income, and Survival in Stage III Colon Cancer: CALGB 89803 (Alliance). JNCI Cancer Spectrum 2021, 5: pkab034-. PMID: 34104867, PMCID: PMC8178799, DOI: 10.1093/jncics/pkab034.Peer-Reviewed Original ResearchMeSH KeywordsAgedBlack PeopleChemotherapy, AdjuvantColonic NeoplasmsConfidence IntervalsDietDisease-Free SurvivalFemaleHealth Services AccessibilityHumansIncomeLife StyleMaleMiddle AgedMultivariate AnalysisNeoplasm Recurrence, LocalNeoplasm StagingProportional Hazards ModelsProspective StudiesWhite PeopleConceptsAdjusted hazard ratioDisease-free survivalRecurrence-free survivalColon cancer patientsHome zip codeMedian household incomeCALGB 89803Hazard ratioOverall survivalCancer patientsStage III colon cancer patientsStage III colon cancerPatient's home zip codeAdjuvant chemotherapy trialsStudy of patientsColon cancer outcomesHealth care accessChemotherapy trialsStudy enrollmentBlack patientsCancer outcomesLifestyle factorsLowest quartileObservational studyPatients
2017
Quantitative Assessment of Visceral Obesity and Postoperative Colon Cancer Outcomes
Ozoya O, Siegel E, Srikumar T, Bloomer A, DeRenzis A, Shibata D. Quantitative Assessment of Visceral Obesity and Postoperative Colon Cancer Outcomes. Journal Of Gastrointestinal Surgery 2017, 21: 534-542. PMID: 28101721, PMCID: PMC5560865, DOI: 10.1007/s11605-017-3362-9.Peer-Reviewed Original ResearchConceptsBody mass indexVisceral obesityPostoperative morbidityObese patientsShort-term postoperative outcomesOverall complication rateColon cancer outcomesMeasures of adiposityColon cancer patientsMetabolic comorbiditiesPostoperative complicationsComplication ratePostoperative outcomesVisceral adipositySurgical morbidityMass indexRisk stratificationRetrospective studyCancer outcomesCancer patientsTomography assessmentPreoperative CTMortality rateStage IColon cancer
2008
AQUA analysis of thymidylate synthase reveals localization to be a key prognostic biomarker in 2 large cohorts of colorectal carcinoma.
Gustavson MD, Molinaro AM, Tedeschi G, Camp RL, Rimm DL. AQUA analysis of thymidylate synthase reveals localization to be a key prognostic biomarker in 2 large cohorts of colorectal carcinoma. Archives Of Pathology & Laboratory Medicine 2008, 132: 1746-52. PMID: 18976010, DOI: 10.5858/132.11.1746.Peer-Reviewed Original ResearchConceptsThymidylate synthase expressionSynthase expressionColorectal carcinomaSignificant associationDisease-specific survivalColon cancer outcomesColon cancer survivalKey prognostic biomarkersRetrospective cohortNodal statusPrognostic valueColorectal cancerCancer outcomesCancer survivalPathologic classificationPrognostic biomarkerLarge cohortSecond cohortAQUA scoreCytoplasmic expressionNuclear expressionCohortHigh nuclearCytoplasmic ratioFirst cohort
2006
Disparities in Colon Cancer Presentation and In-Hospital Mortality in Maryland: A Ten-Year Review
Ahuja N, Chang D, Gearhart SL. Disparities in Colon Cancer Presentation and In-Hospital Mortality in Maryland: A Ten-Year Review. Annals Of Surgical Oncology 2006, 14: 411-416. PMID: 17080235, DOI: 10.1245/s10434-006-9130-9.Peer-Reviewed Original ResearchConceptsLife-threatening symptomsHospital mortalityColon cancerSocioeconomic statusAfrican AmericansMaryland hospital discharge databaseColon cancer presentationHospital mortality rateIn-Hospital MortalityHospital discharge databaseColon cancer outcomesPrimary colon cancerColon cancer patientsHealth care accessOutcomes of interestTen-year reviewHigher socioeconomic statusConclusionsRacial disparitiesUnderwent resectionHospital outcomesCancer presentationSurgical resectionSymptomatic patientsPrehospital factorsPoor outcome
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply